Clinical and Applied Thrombosis/Hemostasis (Aug 2022)

Application of Rotational Thromboelastometry in Patients with Acute Promyelocytic Leukemia

  • Nikica Sabljic MD,
  • Nikola Pantic MD,
  • Marijana Virijevic MD, PhD,
  • Zoran Bukumiric MD, PhD,
  • Tina Novakovic MD,
  • Zlatko Pravdic MD,
  • Jovan Rajic MD,
  • Ana Vidovic MD, PhD,
  • Nada Suvajdzic MD, PhD,
  • Mark Jaradeh BS,
  • Jawed Fareed PhD,
  • Darko Antic MD, PhD,
  • Mirjana Mitrovic MD, PhD

DOI
https://doi.org/10.1177/10760296221119809
Journal volume & issue
Vol. 28

Abstract

Read online

Introduction Hemorrhagic early death (HED) remains a major cause of treatment failure among patients with acute promyelocytic leukemia (APL). We aimed to investigate the prognostic potential of rotational thromboelastometry (ROTEM) for bleeding in patients with APL. Materials and Methods 31 newly-diagnosed APL patients (median age of 40 years; 14 female/17 male) that underwent treatment at the Clinic of Hematology UCCS from 2016-2020 with all-trans retinoic acid and anthracyclines were recruited. CBCs (complete blood count), conventional coagulation tests (CCTs), and ROTEM parameters obtained before treatment initiation were evaluated. Results All patients demonstrated at least one ROTEM parameter out of the reference range. ROTEM parameters associated with significant hemorrhage were EXTEM clotting time (CT) (P = 0.041) and INTEM amplitude 10 (A10) (P = 0.039), however, only EXTEM CT (P = 0.036) was associated with HED. Among CBCs and CCTs, only platelets were associated with significant bleeding (P = 0.015), while D-dimer was associated with both bleeding and HED (P = 0.001 and P = 0.002, respectively). Conclusion Our results indicate that ROTEM parameters may reveal hypocoagulability in APL patients and have the potential to improve current hemorrhage prognostic methods. Additionally, these results suggest the combination of ROTEM and CCTs might be useful in identifying patients at risk for HED.